CBLI

Cleveland BioLabs, Inc. News Headlines

$0.49
*  
0.01
2%
Get CBLI Alerts
*Delayed - data as of Jul. 11, 2014 15:40 ET  -  Find a broker to begin trading CBLI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CBLI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Good News for Cleveland BioLabs - Analyst Blog
4/17/2014 5:20:01 PM - Zacks.com

Healthcare Stocks Ending with Losses; Cleveland Labs Falls to Record Low After Partner Pulls Plug on Radiation Treatment
1/23/2014 4:51:46 PM - MT Newswires

Sector Update: Healthcare
1/23/2014 4:50:38 PM - MT Newswires

Sector Update: Healthcare Stocks Lower; CBLI Slides 42% on Abandoned Development Plans
1/23/2014 9:46:01 AM - MT Newswires

Sector Update: Healthcare
1/23/2014 9:44:30 AM - MT Newswires

Sector Update: Healthcare Shares Flat to Higher; Cleveland BioLabs Cuts Net Loss in Half Year-Over-Year
8/13/2013 8:11:41 AM - MT Newswires

Sector Update: Healthcare
8/13/2013 8:10:55 AM - MT Newswires

Pre-Market Earnings Report for August 13, 2013 : VAL, FLO, AG, GENT, SCR, CACH, CBLI, PFSW, CIMT, ENSV
8/12/2013 4:00:04 PM - NASDAQ.com News

Profiting From BARDA Contract Awards
5/22/2013 1:33:00 PM - Seeking Alpha

Isis Initiates ISIS-STAT3 Study - Analyst Blog
5/7/2013 6:23:52 PM - Zacks.com

Negative Opinion on AVEO/ALPMY Candidate - Analyst Blog
5/3/2013 5:30:50 PM - Zacks.com

Loss at Aegerion Narrower Than Expected - Analyst Blog
5/3/2013 4:29:09 PM - Zacks.com

Gilead Misses on Earnings, Sales in 1Q - Analyst Blog
5/3/2013 8:29:01 AM - Zacks.com

Affymetrix Reports Disappointing 1Q - Analyst Blog
5/2/2013 8:49:01 AM - Zacks.com

Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog
5/1/2013 8:49:18 AM - Zacks.com

Merck - Pfizer in Diabetes Deal - Analyst Blog
4/30/2013 3:51:20 PM - Zacks.com

Double Setback for Gilead - Analyst Blog
4/30/2013 3:47:55 PM - Zacks.com

CHMP in Favor of Celgene's Revlimid - Analyst Blog
4/29/2013 4:49:04 PM - Zacks.com

Geron Narrows Loss; Cuts Jobs - Analyst Blog
4/29/2013 10:03:23 AM - Zacks.com

Earnings Increase at The Medicines Co. - Analyst Blog
4/26/2013 5:22:26 PM - Zacks.com

Biogen's Earnings Surpass Expectations - Analyst Blog
4/25/2013 12:14:51 PM - Zacks.com

Isis Pharma's ISIS-SMNRx Progresses - Analyst Blog
4/24/2013 5:09:50 PM - Zacks.com

Tax Benefit Boosts Amgen Earnings - Analyst Blog
4/24/2013 12:56:01 PM - Zacks.com

Merck - BMY in HCV Deal - Analyst Blog
4/23/2013 6:09:40 PM - Zacks.com

Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks
4/23/2013 9:31:00 AM - Seeking Alpha